Connect your AI

Nuvation Bio NUVB Accounts Receivable, after Allowance for Credit Loss

Accounts Receivable, after Allowance for Credit Loss at other companies

Realty IncomeO

$1.12B+17.3%

MSCIMSCI

$883.2M+17.9%

State StreetSTT

$789M-19.1%

Wells Fargo & CompanyWFC

$26.36B-7.8%

Duke EnergyDUK

$199M-3.9%

Target HospitalityTH

$68.5K+247%

Other financials

Income statement

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

Market cap$2.25B+150%

Enterprise value$2.18B+154%

P/S15.7×-66.3×

Profitability

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNet.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's accounts receivable, after allowance for credit loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Nuvation Bio's accounts receivable, after allowance for credit loss?: Nuvation Bio (NUVB) reported accounts receivable, after allowance for credit loss of $22.72M in Q1 2026.
How has Nuvation Bio's accounts receivable, after allowance for credit loss changed year-over-year?: Nuvation Bio's accounts receivable, after allowance for credit loss increased by 5455.7% year-over-year, from $409K to $22.72M.